Financials

  • Market Capitalization 210.12 M
  • Employee 95
  • Founded N/A
  • CEO Daniel Vitt
  • Website www.imux.com
  • Headquarter Delaware, United States
  • FIGI BBG001M75SX4
  • Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-4.34
Rapporto prezzo/fatturato

Related tickers

#NomePrezzo24h %7d %1M %1Y %Valore di MercatoUltimi 7 Giorni
3589
CRBP
Corbus Pharmaceuticals Holdings, Inc. - Common Stock
10.91 USD-1.98%+6.96%+20.42%-34.28%211.01 M USD
3591
ANTX
AN2 Therapeutics, Inc. - Common Stock
5.58 USD-2.79%-4.12%+4.30%+398.21%210.57 M USD
3594
ORMP
Oramed Pharmaceuticals Inc. - Common Stock
5.03 USD-1.37%+4.57%+22.09%+135.05%209.23 M USD
3596
IPHA
Innate Pharma S.A. - American Depositary Shares
2.23 USD0.00%+0.90%+29.65%+7.21%208.99 M USD

Notizie